Clinical Trial Update: ACTH for Fatigue in Multiple Sclerosis Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ACTH for fatigue in patients with Relapsing-Remitting Multiple Sclerosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Relapsing-remitting

Drugs mentioned

• ACTH (adrenocorticotropic hormone)

Snippet

Sponsor: Providence Health & Services | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 3 | Status: COMPLETED | Results posted: 2019-08-13